Genetic risk score associations for myocardial infarction are comparable in persons with and without rheumatoid arthritis: the population-based HUNT study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 11 2020
Historique:
received: 03 04 2020
accepted: 11 11 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 25 3 2021
Statut: epublish

Résumé

Persons with rheumatoid arthritis (RA) have increased risk of myocardial infarction (MI). Overlapping associations with MI of weighted genetic risk scores (wGRS) for coronary artery disease (CAD) and RA is unknown in a population-based setting. Data from the prospective Nord-Trøndelag Health Study (HUNT2: 1995-1997 and HUNT3: 2006-2008) were used. wGRS added each participant's carriage of all risk variants weighted by the coefficient from published association studies. Published wGRS for CAD and RA were analysed in Cox regression with MI as outcome, age as analysis time, and censoring at the first MI, death, or 31.12.2017. 2609 of 61,465 participants developed MI during follow-up (mean 17.7 years). The best-fitting wGRS for CAD and RA included 157 and 27 single-nucleotide polymorphisms, respectively. In multivariable analysis including traditional CAD risk factors, the CAD wGRS was associated with MI [hazard ratio = 1.23 (95% CI 1.18-1.27) for each SD increase, p < 0.0001] in RA patients (n = 433) and controls. The RA wGRS was not significant (p = 0.06). Independently from traditional risk factors, a CAD wGRS was significantly associated with the risk for MI in RA patients and controls, whereas an RA wGRS was not. The captured genetic risk for RA contributed little to the risk of MI.

Identifiants

pubmed: 33235261
doi: 10.1038/s41598-020-77432-0
pii: 10.1038/s41598-020-77432-0
pmc: PMC7686351
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20416

Références

Int J Epidemiol. 2013 Aug;42(4):968-77
pubmed: 22879362
BMJ. 2017 May 23;357:j2099
pubmed: 28536104
Ann Rheum Dis. 2015 Apr;74(4):668-74
pubmed: 24389293
Pulse (Basel). 2019 Apr;6(3-4):169-186
pubmed: 31049317
PLoS One. 2017 Mar 23;12(3):e0174656
pubmed: 28334012
Nat Genet. 2018 Sep;50(9):1234-1239
pubmed: 30061737
Nat Genet. 2011 Mar 06;43(4):333-8
pubmed: 21378990
Atherosclerosis. 2013 Nov;231(1):163-72
pubmed: 24125429
J Am Coll Cardiol. 2015 Mar 3;65(8):830-845
pubmed: 25720628
Ann Rheum Dis. 2011 Jun;70(6):929-34
pubmed: 21389043
Ann Rheum Dis. 2018 Jan;77(1):48-54
pubmed: 28877868
J Am Coll Cardiol. 2000 Sep;36(3):959-69
pubmed: 10987628
J Rheumatol. 2017 Jan;44(1):4-10
pubmed: 27744395
Circ Genom Precis Med. 2018 Jan;11(1):e001849
pubmed: 29874178
Arthritis Rheumatol. 2015 May;67(8):1995-2003
pubmed: 25989470
J Clin Epidemiol. 2004 Mar;57(3):229-36
pubmed: 15066682
Circulation. 2018 Nov 13;138(20):e618-e651
pubmed: 30571511
Arthritis Rheum. 2005 Feb;52(2):402-11
pubmed: 15693010
J Rheumatol. 2017 Aug;44(8):1134-1141
pubmed: 28412703
Ann Rheum Dis. 2019 May;78(5):683-687
pubmed: 30787006
Lancet. 2010 Sep 25;376(9746):1094-108
pubmed: 20870100
Curr Pharm Des. 2015;21(2):182-201
pubmed: 25163740
Eur J Epidemiol. 2005;20(7):575-9
pubmed: 16119429
Expert Rev Mol Diagn. 2017 Oct;17(10):905-915
pubmed: 28816567
Nat Genet. 2017 Sep;49(9):1385-1391
pubmed: 28714975
PLoS One. 2015 Feb 17;10(2):e0117952
pubmed: 25689371
Arthritis Rheum. 1988 Mar;31(3):315-24
pubmed: 3358796
Trends Cardiovasc Med. 2017 Feb;27(2):136-140
pubmed: 27612551
Circ Res. 2014 Jun 6;114(12):1890-903
pubmed: 24902973
Eur Heart J. 2016 Feb 7;37(6):561-7
pubmed: 26392438
Arthritis Rheumatol. 2019 Mar;71(3):351-360
pubmed: 30251476
Circ Cardiovasc Genet. 2016 Dec;9(6):531-540
pubmed: 27780846
J Rheumatol. 2020 Feb;47(2):204-210
pubmed: 30936278
Autoimmun Rev. 2016 Nov;15(11):1013-1030
pubmed: 27490206
Semin Immunopathol. 2017 Jun;39(4):447-459
pubmed: 28455580
Rheumatology (Oxford). 2020 Jul 1;59(7):1743-1751
pubmed: 31930319
Ann Rheum Dis. 2010 Sep;69(9):1580-8
pubmed: 20699241

Auteurs

S Rostami (S)

Department of Clinical and Molecular Medicine, St. Olavs Hospital, NTNU - Norwegian University of Science and Technology, Lab Center 3 East, 7006, Trondheim, Norway.

M Hoff (M)

Department of Neuromedicine and Movement Science, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Department of Rheumatology, St. Olavs University Hospital, Trondheim, Norway.

H Dalen (H)

Department of Circulation and Medical Imaging, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Clinic of Cardiology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.

K Hveem (K)

KG Jebsen Center for Genetic Epidemiology, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.

V Videm (V)

Department of Clinical and Molecular Medicine, St. Olavs Hospital, NTNU - Norwegian University of Science and Technology, Lab Center 3 East, 7006, Trondheim, Norway. vibeke.videm@ntnu.no.
Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Trondheim, Norway. vibeke.videm@ntnu.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH